November 27th, 2024 2:40 am
Read More...
Tags:
♫ Posted in Eye Sight & Vision | | Comments Off»
November 27th, 2024 2:40 am
Read More...
Tags:
♫ Posted in Eye Sight & Vision | | Comments Off»
November 27th, 2024 2:40 am
Read More...
Tags:
♫ Posted in Eye Sight & Vision | | Comments Off»
November 27th, 2024 2:40 am
Read More...
Tags:
♫ Posted in Eye Sight & Vision | | Comments Off»
November 27th, 2024 2:40 am
Read More...
Tags:
♫ Posted in Eye Sight & Vision | | Comments Off»
November 27th, 2024 2:40 am
Read More...
Tags:
♫ Posted in Eye Sight & Vision | | Comments Off»
November 27th, 2024 2:40 am
Read More...
Tags:
♫ Posted in Eye Sight & Vision | | Comments Off»
November 27th, 2024 2:40 am
Read More...
Tags:
♫ Posted in Eye Sight & Vision | | Comments Off»
November 27th, 2024 2:40 am
Read More...
Tags:
♫ Posted in Eye Sight & Vision | | Comments Off»
November 27th, 2024 2:40 am
Read More...
Tags:
♫ Posted in Eye Sight & Vision | | Comments Off»
November 27th, 2024 2:40 am
Read More...
Tags:
♫ Posted in Eye Sight & Vision | | Comments Off»
November 27th, 2024 2:40 am
Read More...
Tags:
♫ Posted in Eye Sight & Vision | | Comments Off»
November 27th, 2024 2:40 am
Read More...
Tags:
♫ Posted in Eye Sight & Vision | | Comments Off»
November 27th, 2024 2:40 am
Read More...
Tags:
♫ Posted in Eye Sight & Vision | | Comments Off»
November 27th, 2024 2:40 am
Read More...
Tags:
♫ Posted in Eye Sight & Vision | | Comments Off»
November 27th, 2024 2:40 am
Read More...
Tags:
♫ Posted in Eye Sight & Vision | | Comments Off»
November 27th, 2024 2:40 am
Read More...
Tags:
♫ Posted in Eye Sight & Vision | | Comments Off»
November 27th, 2024 2:39 am
NEWTON, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease, announced today that management will participate in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference on Tuesday, Dec. 3, 2024, at 3:00 p.m. ET.
Originally posted here:
Acumen Pharmaceuticals to Participate in the 7th Annual Evercore ISI HealthCONx Conference
Read More...
Tags:
♫ Posted in Global News Feed | | Comments Off»
November 27th, 2024 2:39 am
SAN CARLOS, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced that Raj Puri, M.D., Ph.D. has been promoted to the newly created role of Chief Regulatory Officer. Dr. Puri joined Iovance in March 2022 as Executive Vice President, Regulatory Strategy and Translational Medicine.
Go here to read the rest:
Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer
Read More...
Tags:
♫ Posted in Global News Feed | | Comments Off»
November 27th, 2024 2:39 am
LONDON, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference on Tuesday, December 3, 2024 at 9:35 a.m. Eastern Time.
View post:
Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference
Read More...
Tags:
♫ Posted in Global News Feed | | Comments Off»